Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial compares a combination of clotrimazole and lactulose vaginal suppositories to clotrimazole alone for candidal vulvovaginitis/vaginal candidi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole + Lactulose vaginal suppositories (clotrimazole and lactulose vaginal suppositories)
  • Clotrimazole vaginal suppositories (clotrimazole)

Snippet

Sponsor: AVVA Pharmaceuticals Ltd. | Conditions: Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC) | Phase 2, Phase 3 | Status: RECRUITING